Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy

Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAC) is a significant modality in breast cancer therapy. We sought to characterize prognostic factors in patients scheduled for NAC who had a pretreatment positron-emission tomography paired with diagnostic quality contrast-enhanced computed tomography (CT) (positron-emissi...

Full description

Bibliographic Details
Main Authors:	Mark K Farrugia, Sinjen Wen, Geraldine M Jacobson, Mohamad Adham Salkeni
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	World Journal of Nuclear Medicine
Subjects:	Breast cancer human epidermal growth factor receptor 2 neoadjuvant chemotherapy positron-emission tomography prognostic factors standard uptake value
Online Access:	http://www.wjnm.org/article.asp?issn=1450-1147;year=2018;volume=17;issue=4;spage=275;epage=280;aulast=Farrugia

Similar Items

Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer
by: N. G. Chanchikova, et al.
Published: (2021-01-01)

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-01-01)

Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Mio Mori, et al.
Published: (2021-07-01)

Role of18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in prediction of response to neoadjuvant chemotherapy in pediatric osteosarcoma
by: Jehan Ahmed Younis, et al.
Published: (2019-01-01)

Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
by: Daniel Guimarães Tiezzi, et al.
Published: (2013-05-01)

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
by: Jorge Daniel Oldan, et al.
Published: (2018-01-01)

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
by: Ileana Corbeau, et al.
Published: (2020-09-01)

Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer
by: Cosimo Sperti, et al.
Published: (2020-07-01)

Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in restaging and prognosis of recurrent melanoma after curative surgery
by: Dharmender Malik, et al.
Published: (2019-01-01)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
by: Lisheng Zhu, et al.
Published: (2021-09-01)

Prognostic significance of standardized uptake value on 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma
by: Seyda Turkolmez, et al.
Published: (2017-01-01)

MICROARRAY ANALYSIS OF DNA COPY NUMBER ABERRATION IN BREAST TUMOR: CORRELATION WITH THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY
by: N. V. Litviakov, et al.
Published: (2016-02-01)

State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments
by: Solomayer, Erich-Franz, et al.
Published: (2005-09-01)

The Value of F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Detection of Residual Breast Tumor or Axillary Metastasis after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma of the Breast
by: Kezban Berberoğlu
Published: (2020-01-01)

Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients
by: Claudio Belluco, et al.
Published: (2018-11-01)

Abdominal extranodal lymphoma detection: positron emission tomography/computed tomography can help
by: Mohsen Ahmed Abdelmohsen, et al.
Published: (2020-07-01)

Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy
by: Chad A. Barnes, et al.
Published: (2020-04-01)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
by: Ziping Wu, et al.
Published: (2019-03-01)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
by: Xiang-Bo Wan, et al.
Published: (2020-08-01)

Effect of Herceptin combined with paclitaxel neoadjuvant chemotherapy on the proliferation viability of HER-2 positive breast cancer cell
by: Min He, et al.
Published: (2018-09-01)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
by: Li Chen, et al.
Published: (2021-03-01)

Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients
by: Eslam Abdul Salam Sarhan, et al.
Published: (2020-07-01)

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01)

Positron emission tomography and positron emission tomography-computerized tomography in pediatric patients
by: Patel Chetan, et al.
Published: (2007-01-01)

Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
by: Yan H, et al.
Published: (2020-12-01)

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
by: Iryna Trotsyuk, et al.
Published: (2019-11-01)

Prognostic factors for survival among gastric cancer patients receiving neoadjuvant chemotherapy: A cross sectional study from Turkey
by: Orhan Uzun, et al.
Published: (2020-11-01)

The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
by: Chen ZL, et al.
Published: (2016-05-01)

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer
by: Takaaki Oba, et al.
Published: (2020-02-01)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Andrew McGuire, et al.
Published: (2020-07-01)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
by: Ruo-Xi Wang, et al.
Published: (2018-09-01)

Variable features of 18F-fluorodeoxyglucose positron emission tomography–computed tomography scan in anorectal malignant melanoma: Case reports and review articles
by: Digish Shah
Published: (2020-01-01)

Can positron emission tomography/computed tomography be predictive of diagnostic success in endobronchial biopsies performed through a fiber-optic bronchoscopy in lung cancer?
by: Coskun Dogan, et al.
Published: (2018-01-01)

Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
by: Chen X, et al.
Published: (2017-06-01)

The assessment of incidental thyroid lesions on 18F-fluorodeoxyglucose positron emission tomography/computed tomogrophy: A single centre experience
by: Efnan Algin, et al.
Published: (2017-07-01)

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Dong Chen, et al.
Published: (2021-08-01)

Noise propagation in quantitative positron emission tomography
by: Palmer, Matthew Rex
Published: (2010)

Positron emission tomography-computed tomography for inguinal nodes in vulvar cancer
by: Jorge Daniel Oldan, et al.
Published: (2018-01-01)

Photoacoustic Computed Tomography of Breast Cancer in Response to Neoadjuvant Chemotherapy
by: Li Lin, et al.
Published: (2021-04-01)

Correlation of positron emission tomography/computed tomography scan with smoking, tumor size, stage and differentiation in head and neck cancer patientspositron emission tomography/computed tomography
by: Jordan L Pleitz, et al.
Published: (2017-01-01)